Prosecution Insights
Prosecution Insights
34 pending office actions • 32 art units • 34 examiners • 0 of 34 (0%) have an AI response strategy ready • 43 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 33 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 33 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 21 (62%) |
| §102 only | 4 (12%) |
| §112 only | 3 (9%) |
| No statute on record | 6 (18%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SITTA, GRANT | 1 | 72.2% | +13.6% |
| MILO, MICHAEL | 1 | 49.1% | +55.6% |
| ROZANSKI, MICHAEL T | 1 | 69.5% | +27.9% |
| RICCI, CRAIG D | 1 | 53.5% | +52.6% |
| HINES, JANA A | 1 | 53.2% | +39.3% |
| PADDA, ARI SINGH KANE | 1 | 22.9% | +19.2% |
| NGUYEN, ANDREW H | 1 | 75.1% | +42.5% |
| COFFA, SERGIO | 1 | 61.0% | +33.3% |
| BEISNER, WILLIAM H | 1 | 61.6% | +29.4% |
| KELLY-O'NEILL, YOLANDA LYNNETTE | 1 | 21.4% | +36.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18280653 | METHODS FOR ASSESSING SPECIFICITY OF CRISPR-MEDIATED GENOME EDITING | KELLY-O'NEILL, YOLANDA LYNNETTE | 19d |
| 18291887 | CONTINUOUS MONITORING WITH NANO-DIAMOND HYDROGEL IN MICRONEEDLES | PADDA, ARI SINGH KANE | 83d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18534086 | SYNTHETIC DNA BINDING DOMAIN PEPTIDES AND USES THEREOF | COFFA, SERGIO | 149d overdue |
| 18425731 | PROBIOTICS TO RESCUE MATERNAL IMMUNE ACTIVATION-INDUCED NEURODEVELOPMENT DEFICITS | HINES, JANA A | 119d overdue |
| 19060948 | Lip-based user interface system | SITTA, GRANT | 56d overdue |
| 18708916 | COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE | RICCI, CRAIG D | 45d overdue |
| 18808688 | NON-INVASIVE ESTIMATION OF PROSTATE TISSUE COMPOSITION BASED ON MULTI-PARAMETRIC MRI DATA | ROZANSKI, MICHAEL T | 38d overdue |
| 18847129 | TRANSRADIAL APPROACH/ANGIOGRAPHY BOARD | MILO, MICHAEL | 17d overdue |
| 18280653 | METHODS FOR ASSESSING SPECIFICITY OF CRISPR-MEDIATED GENOME EDITING | KELLY-O'NEILL, YOLANDA LYNNETTE | 19d |
| 18466204 | DEVICE AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES | BEISNER, WILLIAM H | 41d |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 1799 | 2 |
| 2622 | 1 |
| 3786 | 1 |
| 3797 | 1 |
| 1611 | 1 |
| 1645 | 1 |
| 3741 | 1 |
| 1658 | 1 |
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19060948 | Lip-based user interface system | SITTA, GRANT | 2622 | §103 | Non-Final OA | 56d overdue | Pending | Feb 24, 2025 |
| 18847129 | TRANSRADIAL APPROACH/ANGIOGRAPHY BOARD | MILO, MICHAEL | 3786 | §103 | Non-Final OA | 17d overdue | Pending | Sep 13, 2024 |
| 18808688 | NON-INVASIVE ESTIMATION OF PROSTATE TISSUE COMPOSITION BASED ON MULTI-PARAMETRIC MRI DATA | ROZANSKI, MICHAEL T | 3797 | §103 | Non-Final OA | 38d overdue | Pending | Aug 19, 2024 |
| 18708916 | COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE | RICCI, CRAIG D | 1611 | §103 | Non-Final OA | 45d overdue | Pending | May 09, 2024 |
| 18425731 | PROBIOTICS TO RESCUE MATERNAL IMMUNE ACTIVATION-INDUCED NEURODEVELOPMENT DEFICITS | HINES, JANA A | 1645 | §102 | Non-Final OA | 119d overdue | Pending | Jan 29, 2024 |
| 18291887 | CONTINUOUS MONITORING WITH NANO-DIAMOND HYDROGEL IN MICRONEEDLES | PADDA, ARI SINGH KANE | 3791 | §103 | Non-Final OA | 83d | Pending | Jan 24, 2024 |
| 18578190 | MULTI-FUNCTION CATHETER AND METHODS FOR DIAGNOSIS AND/OR TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE | NGUYEN, ANDREW H | 3741 | §103 | Non-Final OA | 49d | Pending | Jan 10, 2024 |
| 18534086 | SYNTHETIC DNA BINDING DOMAIN PEPTIDES AND USES THEREOF | COFFA, SERGIO | 1658 | Other | Non-Final OA | 149d overdue | Pending | Dec 08, 2023 |
| 18466204 | DEVICE AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES | BEISNER, WILLIAM H | 1799 | §103 | Non-Final OA | 41d | Pending | Sep 13, 2023 |
| 18280653 | METHODS FOR ASSESSING SPECIFICITY OF CRISPR-MEDIATED GENOME EDITING | KELLY-O'NEILL, YOLANDA LYNNETTE | 1692 | Other | Non-Final OA | 19d | Pending | Sep 06, 2023 |
| 18266404 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA | BAUSCH, SARAE L | 1699 | Other | Non-Final OA | 12d | Pending | Jun 10, 2023 |
| 18202197 | MULTI-ELEMENT ATOM ARRAY | STOFFA, WYATT A | 2881 | §102 | Non-Final OA | 20d | Pending | May 25, 2023 |
| 18254301 | POROUS AND MONOLITHIC CARBON MEMBRANES AND THEIR USE | HUANG, RYAN | 1777 | §103 | Non-Final OA | 30d | Pending | May 24, 2023 |
| 18138015 | RAPID LEARNING WITH HIGH LOCALIZED SYNAPTIC PLASTICITY | TRAN, QUOC A | 2145 | — | Non-Final OA | 17d overdue | Pending | Apr 21, 2023 |
| 18246512 | ANTI-INFLAMMATORY CYTOKINES AND METHODS OF USE | MERTZ, PREMA MARIA | 1674 | §112 | Non-Final OA | 21d | Pending | Mar 23, 2023 |
| 18172146 | MECHANICALLY ADAPTIVE MATERIALS | NASSIRI MOTLAGH, ANITA | 1734 | §103 | Non-Final OA | 17d overdue | Pending | Feb 21, 2023 |
| 18022004 | MODIFIED SERINE PROTEASE PROPROTEINS | ARMATO JR, DENNIS IGNATIUS | 1651 | §103 | Final Rejection | 15d overdue | Pending | Feb 17, 2023 |
| 18019972 | Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses | RAO, SAVITHA M | 1691 | §112 | Final Rejection | 18d overdue | Pending | Feb 06, 2023 |
| 18006482 | Inhibitors of the Artemin Pathway for Treatment of Cancer | WEBB, WALTER E | 1612 | §103 | Final Rejection | 20d | Pending | Jan 23, 2023 |
| 18088252 | Metrology by Neural Networks | ALGIBHAH, MAHER N | 2165 | §103 | Final Rejection | 5d | Pending | Dec 23, 2022 |
| 17987649 | Mechanism and Methods for Quantifying the Tactile Acuity of the Human Breast | MCCORMACK, ERIN KATHLEEN | 3791 | §103 | Final Rejection | 19d overdue | Pending | Nov 15, 2022 |
| 17917438 | USE OF MASITINIB FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19) | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | §103 | Final Rejection | 77d overdue | Pending | Oct 06, 2022 |
| 17995225 | TOCILIZUMAB FOR THE TREATMENT OF VIRAL INFECTIONS | NICKOL, GARY B | 1643 | §102 | Non-Final OA | 146d overdue | Pending | Sep 30, 2022 |
| 17905116 | METHODS AND COMPOSITIONS COMPRISING TRANS-ACTING TRANSLATIONAL ACTIVATORS | SULLIVAN, STEPHANIE LAUREN | 1635 | Other | Final Rejection | — | Pending | Aug 26, 2022 |
| 17833841 | INORGANIC POROUS COATINGS AND METHODS OF MAKING THE SAME | MCCLURE, CHRISTINA D | 1718 | §103 | Non-Final OA | 45d overdue | Pending | Jun 06, 2022 |
| 17765176 | LAMELLAR IRON SULFIDES WITH EMBEDDED CATIONS FOR ELECTRICAL ENERGY STORAGE | NGUYEN, KEVIN NMN | 1752 | §102 | Final Rejection | 73d overdue | Pending | Mar 30, 2022 |
| 17763445 | METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE AND THALASSEMIA | MAHLUM, JONATHAN DAVIS | 1625 | §103 | Non-Final OA | 88d overdue | Pending | Mar 24, 2022 |
| 17642582 | METHOD AND APPARATUS USING MACHINE LEARNING FOR EVOLUTIONARY DATA-DRIVEN DESIGN OF PROTEINS AND OTHER SEQUENCE DEFINED BIOMOLECULES | ANDERSON-FEARS, KEENAN NEIL | 1687 | §103 | Non-Final OA | 71d | Pending | Mar 11, 2022 |
| 17690726 | Method and System for Converting Electricity into Alternative Energy Resources | HENKEL, DANIELLE B | 1799 | §103 | Final Rejection | 30d overdue | Pending | Mar 09, 2022 |
| 17597793 | COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED THERAPEUTIC AGENTS | PETERS, ALEC JON | 1641 | Other | Non-Final OA | 16d | Pending | Jan 24, 2022 |
| 17596118 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH COLLAGEN BINDING DRUG CARRIERS | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §103 | Final Rejection | 8d overdue | Pending | Dec 03, 2021 |
| 17595098 | NOVEL MATERIAL FOR SKIN WOUND CLOSURE AND SCAR PREVENTION | SCHMIDT, IZABELA MARIA | 1621 | §112 | Non-Final OA | 5d | Pending | Nov 09, 2021 |
| 17311448 | COMPOSITIONS AND METHODS RELATED TO SITE-SPECIFIC IDENTIFICATION OF RNA MODIFICATIONS | VALLE, ERNESTO | 1623 | §103 | Non-Final OA | 79d | Pending | Jun 07, 2021 |
| 17302143 | METHODS AND COMPOSITIONS FOR PROTECTION OF CELLS AND TISSUES FROM COMPUTED TOMOGRAPHY RADIATION | DICKINSON, PAUL W | 1618 | §103 | Final Rejection | 87d overdue | Pending | Apr 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial